“Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.”, J Virol, vol. 87, no. 3, pp. 1708-19, 2013.
, “Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus.”, J Immunol, vol. 190, no. 6, pp. 2495-9, 2013.
,